APVO (APVO) Stock Price & Analysis
APVO (APVO) rose 1.75% to USD 1.74 as of September 8, 2026 at 13:15 UTC, according to Nexqual real-time market data.
APVO last closed at USD 1.74; the session ranged USD 1.64–1.8 on volume of 272,973 shares. Market capitalization is —, with a 52-week range of USD 1.37–48.78 (NCM). Source: Nexqual, September 8, 2026 at 13:15 UTC.
Key Statistics (as of September 8, 2026 at 13:15 UTC)
| Price | USD 1.74 |
|---|---|
| Change | ▲ 1.75% (up) |
| Previous Close | USD 1.74 |
| Open | USD 1.74 |
| Day Range | USD 1.64 – 1.8 |
| 52-Week Range | USD 1.37 – 48.78 |
| Volume | 272,973 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (APVO)
Nexqual's technical model rates APVO "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 13:15 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 23.02 (oversold) |
| vs SMA50 | Below (USD 3.69) |
| MACD | -0.51 (negative) |
From APVO's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.33 | ▲ 2.71% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▼ 4.42% |
| KZIA | Kazia Therapeutics Limited | USD 12.31 | ▼ 2.38% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.58 | ▲ 0% |
| ISPC | iSpecimen Inc. | USD 1.54 | ▲ 3.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:15 UTC. This page is informational and not investment advice.